Navigation Links
Old Defibrillators Safe for Re-use
Date:11/16/2010

TUEDAY, Nov. 16 (HealthDay News) -- Implantable cardioverter defibrillators (ICDs) that are removed from patients -- either because of infections or for necessary upgrades -- can be safely used again for new patients, new research indicates.

The observation is based on a small study of 31 patients in India who had ICDS implanted that had already been used and removed from other patients.

The study, led by Dr. Behzad Pavri, an associate professor of medicine at Thomas Jefferson University in Philadelphia, is slated for presentation Tuesday at the American Heart Association annual meeting in Chicago.

Before re-implantation, all the removed ICDS (which had a battery life of 70 percent or more when extracted from the original pool of patients) were cleaned and sterilized.

In turn, they were implanted in patients diagnosed with a life-threatening irregular heart beat condition (arrhythmia). Pavri and his colleagues noted that the recipients would have been too poor to afford new ICD devices outside of the study.

The authors followed the patients for an average of two years and two months. During that time, none of the patients experienced ICD-related infections, and more than 40 percent got the expected life-sustaining shocks such devices are designed to deliver when appropriate.

About 16 percent of the patients did, however, have to receive a second re-sterilized, used ICD three years following the first implant when the battery finally expired.

If the findings hold up upon further investigation, the authors suggest that their re-use strategy could have be beneficial for low-income populations down the road.

More information

For more on ICDs, visit the American Heart Association.

SOURCE: American Heart Association Meeting, news release, November 16, 2010.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. University of Colorado in pilot project to map defibrillators
2. External Defibrillators Not Much Help in Hospitals
3. New Software for Defibrillators Lowers Risk of Unnecessary Shocks
4. As End of Life Nears, What to Do With Implanted Defibrillators?
5. Public Defibrillators Save Lives
6. Widespread Public Defibrillators May Save Lives
7. Hospices not deactivating defibrillators in patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Old Defibrillators Safe for Re-use
(Date:3/22/2017)... ... March 22, 2017 , ... ... leading digital and print media enterprise focused on cancer patients, cancer centers and ... released a special 12-part educational video series, “No Ifs, Ands, or Butts,” that ...
(Date:3/22/2017)... ... 22, 2017 , ... The Rett Syndrome Research Trust (RSRT) ... that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in ... females. Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... to its Department of Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular ... surgery. She is board-certified in both Orthopedics and Hand Surgery. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Norwich, NY (PRWEB) , ... March 22, 2017 , ... ... to communities in the greater Nassau County region, is embarking on a combined charity ... breast cancer. , For the last 25 years, the Great Neck Breast Cancer ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... March 22, 2017 AMRI , a ... been working with the life sciences industry to improve ... 25 years, has been recognized for its excellence as ... as part of the Life Science Leader,s 2017 ... expertise, quality and reliability. "Competing with ...
(Date:3/22/2017)... STOCKHOLM , March 22, 2017 ... biopharmaceutical company developing novel anticancer therapies targeting the ... with Memorial Sloan Kettering Cancer Center to study ... p53 by APR-246. The goal of ... efficacy of APR-246 in combination with multiple other ...
(Date:3/22/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 14.58% during the period ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology: